• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VERYAN MEDICAL BIOMIMICS 3D VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VERYAN MEDICAL BIOMIMICS 3D VASCULAR STENT SYSTEM Back to Search Results
Catalog Number 131816-14
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ischemia (1942); Occlusion (1984); Thrombus (2101)
Event Date 12/06/2019
Event Type  Injury  
Manufacturer Narrative
There was no reported device malfunction and the device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effects of ischemia, occlusion and thrombosis are listed in the biomimics 3d instructions for use and are known patient effects of peripheral stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available a follow-up report will be submitted.
 
Event Description
The patient was treated as part of the mimics-3d european post-market observational study on (b)(6) 2018.At index procedure (((b)(6) 2018), the patient presented with a de-novo occlusion of the segment involving the middle third of the superficial femoral artery (sfa) and the distal third of the sfa of the left leg.One 6.0 x 125mm biomimics stent was implanted.On (b)(6) 2019 an event of ischemia was reported.This event was not related to the device or the procedure but was described as an intercurrent intervention.Percutaneous intervention took place on the (b)(6) 2019 and involved bare metal stent, drug coated balloon / drug eluting balloon and percutaneous transluminal angioplasty /standard balloon angioplasty and thrombolysis of the segment between the middle third of the sfa and distal popliteal artery.The outcome of the event is that it has resolved and patient has recovered.The device remains implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMIMICS 3D VASCULAR STENT SYSTEM
Type of Device
BIOMIMICS 3D VASCULAR STENT SYSTEM
Manufacturer (Section D)
VERYAN MEDICAL
unit 11 galway technology park
parkmore
co. galway, H91 V E0H
EI  H91 VE0H
Manufacturer Contact
alan mcdonagh
unit 11 galway techology park
parkmore
galway city, H91 V-E0H
EI   H91 VE0H
MDR Report Key9670714
MDR Text Key186525934
Report Number3011632150-2020-00002
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
PMA/PMN Number
P180003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,study
Reporter Occupation Physician
Type of Report Initial
Report Date 02/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/05/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date06/30/2018
Device Catalogue Number131816-14
Device Lot Number364194
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/06/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/07/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age85 YR
Patient Weight66
-
-